By contrast, the cfl1 MOs showed severe interference with the progression of gastrulation (data will be described later).
In line with the decline in swollen joint count and CRP at baseline, which are the major variables associated with the progression of joint damage, 61 62 these data suggest that the standard of care (for the pool of patients from which clinical trial patients are obtained) has improved during the past decade.
With the progression of technology and the gradual accumulation of data, we will eventually have a variety of HLA-type pentamers at our disposal and will be able to choose antigens with stronger immunogenicity that encompass more patients.
We noted that growth kinetics gradually became slower with the progression of the tumor passages in vivo (data not shown).
In the present study, only ΔA1C was associated with the progression of liver fibrosis, but not liver inflammation (data not shown).
Finally, we will perform UV-Visible and fluorescence spectroscopy of rabbit serum at different time points (for example 4, 8, and 12 weeks) instead of only one time point (12 weeks), after feeding with HCD to monitor whether the UV-Vis/fluorescent spectroscopy data correlate with the progression of atherosclerosis.
There is no data with regard to the progression of hepatic injury with continued therapy in patients with mildly elevated liver enzymes; however, a recent study showed that patients with mild aminotransferase elevation at baseline did not show a progressive rise in liver enzymes after a mean follow-up of 2 years of therapy [ 74].
Taken together, these TMA data suggest that TPL2 expression is upregulated with the progression of prostate cancer.
These data suggest how atrophy rates accelerate through the brain with the progression of cognitive decline.
From the data we conclude that the TRPV6 genotype does not correlate with the progression of prostatic adenocarcinoma.
The data exhibit spatial-temporal patterns of BM property regulation that coincide with the progression of adapted physiology.
